PATENT CLAIM ANALYSIS

Application Number: 16059439
Application Type: Utility
Filing Date: 2018-08
Publication Date: 2019-02
Patent Classification: ["424", "078320"]

Abstract:
The present invention is directed to a pharmaceutical composition comprising the compound suvorexant, or a pharmaceutically acceptable salt thereof, a concentration-enhancing polymer, and optionally a pharmaceutically acceptable surfactant.

Claim (Index 5):
The pharmaceutical composition of  claim 4 , wherein the concentration-enhancing polymer is hydroxypropyl methyl cellulose acetate succinate (HPMCAS).

Metadata:
- Claim Count in Document: 1.0
- Percentile: 96.0
- Lexical Diversity: 1.28
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['14404147', '15305246', '14002221', '12386402', '11897940']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7406504814135059
- 35 USC 102 Novelty (BERT): 0.5389158237710673
- Combined Prediction Score: 0.7204770156492619
- Mean Citation Score: 257.12224
- Max Citation Score: 385.5299
- Similarity Product: 225.9575049539924

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test